gp100:209-217(210M) peptide vaccine

{
  "id": "MLC-T-ONC-014018",
  "term": "gp100:209-217(210M) peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic peptide cancer vaccine consisting of amino acid residues 209 through 217 of the glycoprotein 100 (gp100) melanoma antigen, with a methionine substitution at position 210 designed to improve immunogenicity. Vaccination with gp100:209-217(210M) peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells expressing gp100.",
  "abbreviation": "G9 209-2M",
  "synonyms": [
    "gp100:209-217(210M)"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/gp100-209-217-210m-peptide-vaccine/"
}